San Francisco, CA, United States of America

Leanna Staben

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • San Francisco, CA (US) (2012 - 2023)
  • South San Francisco, CA (US) (2020 - 2023)

Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Unveiling the Inventive Journey of Leanna Staben

Introduction:

Leanna Staben, a prolific inventor hailing from San Francisco, CA, has made significant strides in the field of pharmaceutical innovations. With a total of 13 patents to her name, Staben's contributions have been particularly noteworthy in the realm of cancer treatment advancements.

Latest Patents:

Staben's ingenuity shines through in her latest patents, which include groundbreaking inventions such as peptidomimetic compounds and antibody-drug conjugates for the prevention and treatment of cancer. Additionally, her work on PROTAC antibody conjugates has opened new avenues in targeted protein degradation for treating various diseases and conditions.

Career Highlights:

Having worked at esteemed companies like Genentech, Inc. and MedImmune Limited, Staben has garnered invaluable experience and expertise in the pharmaceutical industry. Her innovative solutions have not only earned her recognition but have also positively impacted the field of medicine.

Collaborations:

Throughout her career, Staben has had the privilege of collaborating with accomplished professionals in the industry. Notable coworkers such as Thomas Pillow and John A. Flygare have been instrumental in bringing her inventive ideas to fruition, further solidifying her position as a trailblazer in the field.

Conclusion:

In conclusion, Leanna Staben's remarkable journey as an inventor underscores her unwavering commitment to advancing healthcare through pioneering pharmaceutical inventions. Her relentless pursuit of innovative solutions continues to inspire and drive progress in the fight against debilitating diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…